Intriguingly, mice genetically engineered to lack hepatic HNF4α develop MASLD, yet exhibit low blood lipid levels and are atherosclerosis-resistant112,113. This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatotic liver disease.